NCT06338696

Thailand ATTR-CM Registry

Thailand Transthyretin Amyloid Cardiomyopathy Registry

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 105 (estimated)
• Sponsor: Mahidol University · Academic / Other
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Accepted

Summary

The investigators of this registry aim to study the natural history, clinical presentation, characteristics, and imaging findings of patients diagnosed with ATTR amyloidosis in Thailand longitudinally. This will enable the investigators to study this disease in depth. With a better understanding, the investigators can aim to develop early screening programs for at-risk patients, raising awareness among non-cardiologists. As amyloid-specific therapies have now become available in Thailand, the findings of this registry can be helpful for epidemiological studies in Thailand.

Conditions

• Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Interventions

Type	Name	Description
OTHER	No intervention	No intervention

Timeline

• Start date: 2024-07-30
• Primary completion: 2029-06-01
• Completion: 2030-06-30
• First posted: 2024-04-01
• Last updated: 2025-05-08

Locations

8 sites across 1 country: Thailand